// App-Quantinova.ai

: Safety profile of a novel peptide, PIN201104, with potential to act as a disease modifying, broad spectrum treatment for asthma

Researchers

Presenter

  • Jeannette Watson

Principal Investigators

  • Donata Federici-Canova

  • Nicky Cooper

  • Clare Burgess

Medical Centers

  • Peptinnovate, Stevenage, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Cardiorenal syndrome

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved